PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability
PERCEPIC
Performance of the Pulmonary Embolism Rule-out Criteria (the PERC Rule) Combined With Implicit Low Clinical Probability (Gestalt) to Rule-out PE Without Further Exams
1 other identifier
observational
1,773
2 countries
12
Brief Summary
PERC rule was created to rule out pulmonary embolism (PE) without further exams, with residual PE risk \<2%. Its safety is currently confirmed in low PE prevalence populations as north-American. In European high PE prevalence population, it has been showed that PERC rule used alone or associated with low clinical probability assessed by revised Geneva score (RGS) was not safe. In retrospective study, we suggest that the combination of PERC rule with implicit clinical probability (gestalt) could allow the use of the PERC rule. PERCEPIC, an observational prospective multicenter study performed in France and Belgium, will test this hypothesis. Therefore, 3000 patients will be included in 12 centers. Primary outcome will be the rate of thromboembolic events or death related or possibly related to PE in patients with low implicit clinical probability and negative PERC rule (8 criteria absents). Upper limit of confidence interval of this rate must be equal or lower than 3% to consider PERC rule as safe in this combination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2015
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2015
CompletedFirst Posted
Study publicly available on registry
February 10, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedSeptember 22, 2016
September 1, 2016
1.2 years
February 5, 2015
September 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the accuracy of the combination of low implicit clinical probability (gestalt) and negative PERC rule (8 criteria absents)
Rate of thromboembolic events or death related or possibly related to PE in patients with low implicit clinical probability and negative PERC rule. Upper limit of confidence interval of this rate must be equal or lower than 3% to consider PERC rule as safe in this combination
3 months
Secondary Outcomes (3)
To assess usefulness of PERC and implicit low clinical probability combination to reduce the use of further exams
During emergency managment
To assess the accuracy of PERC and low clinical probability combination depending of clinical probability assessment method (implicit assessment, revised Geneva Score, Wells Score and implicit overridden Geneva Score)
3 months
To compare performances of clinical probability assessment methods : implicit assessment, revised Geneva Score, Wells Score and implicit overridden Geneva Score
3 months
Interventions
Eligibility Criteria
All patients admitted to the emergency department for dyspnea or thoracic pain without another obvious cause or suspected PE
You may qualify if:
- \- Patients admitted to the emergency department for one of the following criteria :
- Dyspnea and/or Thoracic pain without another obvious cause
- Pulmonary embolism suspicion whatever the reason
You may not qualify if:
- Age lower than 18
- Patients hospitalized for more than 48h
- Ongoing curative anticoagulant therapy for more than 48h before admission
- Patients with thromboembolic disease diagnosed before the admission
- Unavailability for follow-up (short life expectancy, no phone number…)
- Patient refusing to be contacted by phone at 3 month
- Patient refusing that medical data were collected
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Clinique Universitaire Saint-Luc
Brussels, Belgium
UH Erasme
Brussels, Belgium
UH Liège
Liège, Belgium
Hospital of Agen
Agen, France
UH Angers
Angers, France
Hospital of Argenteuil
Argenteuil, France
UH Clermont-Ferrand
Clermont-Ferrand, France
Hospital of Le Mans
Le Mans, France
UH Nantes
Nantes, France
UH Poitiers
Poitiers, France
UH Rennes
Rennes, France
Hospital of Saint-Brieuc
Saint-Brieuc, France
Related Publications (1)
Penaloza A, Soulie C, Moumneh T, Delmez Q, Ghuysen A, El Kouri D, Brice C, Marjanovic NS, Bouget J, Moustafa F, Trinh-Duc A, Le Gall C, Imsaad L, Chretien JM, Gable B, Girard P, Sanchez O, Schmidt J, Le Gal G, Meyer G, Delvau N, Roy PM. Pulmonary embolism rule-out criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study. Lancet Haematol. 2017 Dec;4(12):e615-e621. doi: 10.1016/S2352-3026(17)30210-7. Epub 2017 Nov 14.
PMID: 29150390DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pierre-Marie ROY, MD-PhD
UH Angers
- STUDY DIRECTOR
Andréa PENALOZA, MD-PhD
Clinique Universitaire Saint-Luc, Bruxelles
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2015
First Posted
February 10, 2015
Study Start
May 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
September 22, 2016
Record last verified: 2016-09